{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:50:10Z","timestamp":1761177010316,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.tracli.2021.05.002","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T12:24:05Z","timestamp":1620390245000},"page":"308-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors"],"prefix":"10.1016","volume":"28","author":[{"given":"N.","family":"Bansal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Raturi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2021.05.002_bib0095","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jmv.25678","article-title":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle","volume":"92","author":"Lu","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.tracli.2021.05.002_bib0100","doi-asserted-by":"crossref","first-page":"106054","DOI":"10.1016\/j.ijantimicag.2020.106054","article-title":"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies","volume":"56","author":"Sharma","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tracli.2021.05.002_bib0105","doi-asserted-by":"crossref","first-page":"103063","DOI":"10.1016\/j.transci.2021.103063","article-title":"A look-back at convalescent plasma to treat COVID-19","volume":"60","author":"Garraud","year":"2021","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2021.05.002_bib0110","first-page":"e2020175","article-title":"Current perspectives of convalescent plasma therapy in COVID-19","volume":"91","author":"Sahu","year":"2020","journal-title":"Acta Biomed"},{"key":"10.1016\/j.tracli.2021.05.002_bib0115","doi-asserted-by":"crossref","first-page":"e00072","DOI":"10.1128\/CMR.00072-20","article-title":"Convalescent plasma therapy for COVID-19: state of the art","volume":"33","author":"Focosi","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tracli.2021.05.002_bib0120","doi-asserted-by":"crossref","first-page":"102867","DOI":"10.1016\/j.transci.2020.102867","article-title":"Life-saving effect of convalescent plasma treatment in covid-19 disease: clinical trial from eastern Anatolia","volume":"59","author":"Erkurt","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2021.05.002_bib0125","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood.2020006964","article-title":"Use of convalescent plasma in hospitalized patients with COVID-19: case series","volume":"136","author":"Hegerova","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2021.05.002_bib0130","article-title":"Hospitalized COVID-19 patients treated with convalescent plasma in a mid-size city in the Midwest. Preprint","author":"Hartman","year":"2020","journal-title":"Res Sq"},{"key":"10.1016\/j.tracli.2021.05.002_bib0135","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood.2020007079","article-title":"Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion","volume":"136","author":"Xia","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2021.05.002_bib0140","doi-asserted-by":"crossref","first-page":"m3939","DOI":"10.1136\/bmj.m3939","article-title":"Convalescent plasma in the management of moderate COVID-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) [published correction appears in BMJ. 2020 Nov 3;371:m4232]","volume":"371","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.tracli.2021.05.002_bib0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/infdis\/jiaa228","article-title":"Effect of convalescent plasma therapy on viral shedding and survival in patients with coronavirus disease 2019","volume":"222","author":"Zeng","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tracli.2021.05.002_bib0150","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa2033700","article-title":"Early high-titer plasma therapy to prevent severe COVID-19 in older adults","volume":"384","author":"Libster","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2021.05.002_bib0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.tracli.2020.04.004","article-title":"A quick \u201cCan I donate blood\u201d self-assessment tool amid the COVID-19 outbreak","volume":"27","author":"Raturi","year":"2020","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2021.05.002_bib0160","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.tracli.2020.08.005","article-title":"Recognizing the role of transfusion medicine specialist in the modern era","volume":"27","author":"Raturi","year":"2020","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2021.05.002_bib0165","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1126\/science.abd0831","article-title":"Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies","volume":"369","author":"Baum","year":"2020","journal-title":"Science"},{"unstructured":"American Association of Blood Banks, Updated information on donation of CPP, blood components and HCT\/ Ps during the COVID-19 pandemic. Updated 2021-04-14. [Last accessed 2021-4-21]. https:\/\/www.aabb.org\/docs\/default-source\/default-document-library\/regulatory\/summary-of-blood-donor-deferral-following-covid-19-vaccine-and-ccp-transfusion.pdf?sfvrsn=91eddb5d_2.","key":"10.1016\/j.tracli.2021.05.002_bib0170"},{"key":"10.1016\/j.tracli.2021.05.002_bib0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.tracli.2021.04.002","article-title":"COVID-19 vaccination in the Indian blood donors: adjudging the impact on the deferral period","author":"Bansal","year":"2021","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2021.05.002_bib0180","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2103825","article-title":"SARS-CoV-2 antibody response in persons with past natural infection","author":"Anichini","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782021000720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782021000720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:38:57Z","timestamp":1761129537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782021000720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1246782021000720"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2021.05.002","relation":{},"ISSN":["1246-7820"],"issn-type":[{"type":"print","value":"1246-7820"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2021.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}